Analyzing the Varied Mechanisms of Action of Existing NASH Candidates to Compare & Contrast Their Ability to Influence Fibrosis & Inflammation in the Liver

Time: 2:30 pm
day: Day 1 Stream 1 PM


• Reviewing the current landscape of NASH candidates and key mechanistic targets, discuss the importance of the combination approach.
• Focusing on targeting metabolic aspects of NASH and how reducing lipid accumulation influences downstream inflammation and fibrosis.
• Discussing Cotadutide and dual-action at GLP-1 and glucagon receptors influence multiple metabolic and liverspecific outcomes. Highlight new data.